Morning Movers Gapping Up $EverQuote (EVER.US)$shares surged 26% after Q4 earnings beat expectations: GAAP EPS reached $0.33 (up by $0.13) and revenue jumped 165% Y/Y to $147.45M. Q1 2025 guidance projects $155–$160M revenue, with robust growth in marketing spend and adjusted EBITDA reinforcing momentum. $Li Auto (LI.US)$shares jumped 13% premarket after the company unveiled its first electric SUV, the Li i8. The model quickly be...
NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (pres...
Huaw
:
I do not understand why HMR only had a total of 28.37 million shares yesterday. Today, it has become a total of 56.75 million shares. It's almost doubled, and the Market Cap has also doubled. Why is this happening?
Investors are ignoring EverQuote's limited growth expectations, paying for exposure despite the risk. The predicted future revenues may not support a positive sentiment for long, placing investments at risk.
Insider sale below current stock price suggests they see this as a fair value, a potential negative signal. Ownership shows alignment between management and small shareholders, but past sales warn caution before buying.
B Riley Securities has upgraded EVER and QNST to Buy from Neutral, based on optimism about auto insurance recovery and EverQuote's cost-cutting measures, and decision to focus on core competency by leaving health insurance.
Gainers: •$Belite Bio (BLTE.US)$+17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1) •$Atkore (ATKR.US)$+12.11% (earnings reports) •$AST SpaceMobile (ASTS.US)$+9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing) •$Harmonic (HLIT.US)$+7.56% (earnings reports) •$The Chemours (CC.US)$+7.2% ...
Upgrades •$Agora (API.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50 •$argenx SE (ARGX.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278) •$Idacorp (IDA.US)$: Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108) •$Jakks Pacific (JAKK.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $21 •$Coca-Cola FEMSA (KOF.US)$: Barclays Upgrades to Overweight from Equal Wei...
$Roku Inc (ROKU.US)$Keybanc cut Roku, Inc. ROKU price target from $490 to $460 $EverQuote (EVER.US)$JP Morgan reduced EverQuote, Inc. EVER price target from $41 to $17 $Triterras (TRIT.US)$B. Riley Securities cut the price target on Triterras, Inc. TRIT from $9 to $5
7
Report
No comment yet
- No more -
Sign in to post a comment
Market Insights
Best Growth Stocks Best Growth Stocks
Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
EverQuote Stock Forum
Gapping Up
$EverQuote (EVER.US)$ shares surged 26% after Q4 earnings beat expectations: GAAP EPS reached $0.33 (up by $0.13) and revenue jumped 165% Y/Y to $147.45M. Q1 2025 guidance projects $155–$160M revenue, with robust growth in marketing spend and adjusted EBITDA reinforcing momentum.
$Li Auto (LI.US)$ shares jumped 13% premarket after the company unveiled its first electric SUV, the Li i8. The model quickly be...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (pres...
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...
• $Agora (API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE (ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp (IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific (JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA (KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...
$EverQuote (EVER.US)$ JP Morgan reduced EverQuote, Inc. EVER price target from $41 to $17
$Triterras (TRIT.US)$ B. Riley Securities cut the price target on Triterras, Inc. TRIT from $9 to $5
No comment yet